CEACAM5 and breast cancer: However, compared with these three miRNAs, CEA and CA153 have lower diagnostic efficacy (diagnosis of BC, 0.5679 AUC, 50.00% sensitivity, 66.02% specificity; diagnosis of early-stage BC, 0.5871 AUC, 55.14% sensitivity, 66.02% specificity).